Exploring the role of HIF-1α on pathogenesis in Alzheimer’s disease and potential therapeutic approaches
Inflammopharmacology · 2025-02 · 33 (2) · 669-678
DOI: 10.1007/s10787-024-01585-x ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammopharmacology, online erschienen am 27.10.2024. Verfasst von Pratyush Porel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, ISF College of Pharmacy, Moga, 142001, Punjab, India. Hauptthemen laut MEDLINE: Alzheimer Disease, Hypoxia-Inducible Factor 1, alpha Subunit. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 76 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Hypoxia-inducible factor 1α (HIF-1α) is a crucial transcription factor that regulates cellular responses to low oxygen levels (hypoxia). In Alzheimer's disease (AD), emerging evidence suggests a significant involvement of HIF-1α in disease pathogenesis. AD is characterized by the accumulation of amyloid-beta (Aβ) plaques and neurofibrillary tangles (NFTs), leading to neuronal dysfunction and cognitive decline. HIF-1α is implicated in AD through its multifaceted roles in various cellular processes. Firstly, in response to hypoxia, HIF-1α promotes the expression of genes involved in angiogenesis, which is crucial for maintaining cerebral blood flow and oxygen delivery to the brain. However, in the context of AD, dysregulated HIF-1α activation may exacerbate cerebral hypoperfusion, contributing to neuronal damage. Moreover, HIF-1α is implicated in the regulation of Aβ metabolism. It can influence the production and clearance of Aβ peptides, potentially modulating their accumulation and toxicity in the brain. Additionally, HIF-1α activation has been linked to neuroinflammation, a key feature of AD pathology. It can promote the expression of pro-inflammatory cytokines and exacerbate neuronal damage. Furthermore, HIF-1α may play a role in synaptic plasticity and neuronal survival, which are impaired in AD. Dysregulated HIF-1α signaling could disrupt these processes, contributing to cognitive decline and neurodegeneration. Overall, the involvement of HIF-1α in various aspects of AD pathophysiology highlights its potential as a therapeutic target. Modulating HIF-1α activity could offer novel strategies for mitigating neurodegeneration and preserving cognitive function in AD patients. However, further research is needed to elucidate the precise mechanisms underlying HIF-1α dysregulation in AD and to develop targeted interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, ISF College of Pharmacy, Moga, 142001, Punjab, India.
- Department of Pharmacy Practice, ISF College of Pharmacy, Moga, 142001, Punjab, India.
- Department of Pharmacology, ISF College of Pharmacy, Moga, 142001, Punjab, India. bishalarann@gmail.com.
Zitieren
APA
Porel, P., Bala, K., & Aran, K. R. (2025). Exploring the role of HIF-1α on pathogenesis in Alzheimer’s disease and potential therapeutic approaches. Inflammopharmacology, 33(2), 669-678. https://doi.org/10.1007/s10787-024-01585-x
Vancouver
Porel P, Bala K, Aran KR. Exploring the role of HIF-1α on pathogenesis in Alzheimer’s disease and potential therapeutic approaches. Inflammopharmacology. 2025;33(2):669-678. doi:10.1007/s10787-024-01585-x
BibTeX
@article{Porel2025,
author = {Porel, Pratyush and Bala, Kanchan and Aran, Khadga Raj},
title = {Exploring the role of HIF-1α on pathogenesis in Alzheimer’s disease and potential therapeutic approaches},
journal = {Inflammopharmacology},
year = {2025},
volume = {33},
number = {2},
pages = {669--678},
doi = {10.1007/s10787-024-01585-x}
}
EUVIMED